1. Parkin DM, Pisai P, Farley J. Estimates of the world-wide Incidence of 25 major cancers in 1990. Int J Cancer 1999;80:827-41.
2. Hall HI, Miller DR, Rogers JD et al. Update of the incidence and mortality from melanoma in USA. J Am Acad Dermatol 1999;40:35-42.
3. Wingo PA, Ries LA, Rosenberg HM. Cancer incidence and mortality 1973-1995: A report card for US cancer 1998;82:1197-207.
4. Hall HI, Miller DR, Rogers JD et al. Update on the incidence and mortality for melanoma in USA: J Am Acad Dermatol 1998:40:35-42.
5. Mathers C, Penm R, Sanson-Fisher R, Campbell E. Health System Costs of Cancer in Australia 1993-94, Canberra: Australian Institute of Health and Welfare, 1998.
6. Baron JA. Prevention of non-melanoma skin cancer: Arch Dermatol 2000; 136:200-45.
7. Armstrong BK. Melanoma: Childhood or lifelong sun exposure. In Grob JJ, Stern RS, MacKie RM, Weinstock WA, eds. Epidemiology, Causes and Prevention of Skin Diseases. Oxford: Blackwell Science, 1997.
8. Tucker MA, Halpen A, Holly EA et al. Clinically recognized dysplastic nevi: a central risk factor for cutaneous melanoma: JAMA 1996;277:1439-44.
9. Elwood JM, Jobson J. Melanoma and sun exposure: an overview of published studies: Int J Cancer 1997;73:198-203.
10. Severi G, Giles GG, Robertson C, Boyle P, Autier P. Mortality from cutaneous melanoma: evidence for contrasting trends between populations. Br J Cancer 2000;82:1887-91.
11. Whiteman DC, Whiteman CA, Green AC. Childhood sun exposure as a risk factor for melanoma a systematic review of epidemiological studies. Cancer Causes Control 2001;1:69-82.
12. Zeigler A, Jonason A, Simon J, Leffell D, Brash DE. Tumour suppressor gene mutations and photocarcinogenesis: Photochem Photobiol 1996;63:432-5.
14. Ouhtit A, Ueda M, Nakazawa H et al. Quantitative detection of ultra-violet light-specific p53 mutations in normal skin from Japanese patients. Cancer Epidemiol Biomarkers Prev 1997;6:433-8.
15. Girgis A. Unpublished review of sun protection studies. Faculty of Behavioural Health Science, University of Newcastle, New South Wales, 1998.
16. Girgis A, Sanson-Fisher RW, Tripodi DA, Golding T. Evaluation of interventions to improve solar protection in primary schools. Health Educ Q 1993;20:275-87.
17. Girgis A, Campbell EM, Redman S, Sanson-Fisher RW. Screening for melanoma: a community survey of prevalence and predictors. Med J Aust 1991;154:338-43.
18. Girgis A, Sanson-Fisher RW, Watson A. A workplace intervention for increasing outdoor workers' use of solar protection. Am J Pub Health 1994;84:77-81.
19. Hill D, White V, Marks R, Baland R. Primary prevention of skin cancer: where to now in reducing sunlight exposure? Eur J Cancer Prev 1993;6:447-56.
20. Robinson JK. Compensation strategies in sun protection behaviours by a population with non-melanoma skin cancer. Prev Med 1992;21:754-65.
21. Berwick M, Fine JA, Bolognia JL. Sun exposure and sunscreen use following a community skin cancer screening. Prev Med 1992;21:302-10.
22. Moise AF, Gies HP, Harrison SL. Estimation of the annual solar UVR exposure dose of infants and small children in tropical Queensland, Australia. Photochem Photobiol 1999;69:457-63.
23. Scott D, Weston R. Evaluating Health Promotion. Cheltenham: Nelson Thorne, 1998.
24. Schofield MJ, Edwards K, Pearce R. Effectiveness of two sun protection policy disseminations strategies in New South Wales primary and secondary schools. Aust N Z J Public Health 1997;21:743-50.
25. Horsley L, Charlton A, Wiggett C. Current action for skin cancer risk reduction in English schools: a report on a survey carried out for the Department of Health. Health Educ Res 2000;15:249-59.
26. IARC. Handbooks on Cancer Prevention (Vol. 3) Vitamin A. Lyon, France: IARC Press, 1998.
27. IARC. Handbooks on Cancer Prevention (Vol. 2) Carotenoids. Lyon, France: IARC Press, 1998.
28. IARC. Handbooks on Cancer Prevention (Vol. 4) Retinoids (Vol. 4) Lyon, France: IARC Press, 1999.
29. The Isotretinoin-Basal Cell Carcinoma Study Group. Long-term therapy with low dose isotretinoin for prevention of basal cell carcinoma: a multi-centre clinical trial. J Natl Cancer Inst 1993;84:328-32.
30. The Skin Cancer Prevention Study Group. A clinical trial of beta-carotene to prevent basal cell and squamous cell cancers of the skin. New Engl J Med 1990;323:789-95.
31. Clark LC, Combs GF, Turnbull BW et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized controlled trial. JAMA 1996;276:1957-63.
32. Feskanich D, Hunter DJ, Willet WC et al. Oral contraceptive use and risk of melanoma in premenopausal women. Br J Cancer 1999;81:918-23.
33. Blois MS, Sagebiel RW, Abarnanel RM et al. Malignant melanoma of the skin: the association of tumour depth and type, and patient sex, age and site with survival. Cancer 1983;52:1330-41.
34. Friedman RJ, Rigel DS, Kopf AW. Early detection of malignant melanoma: the role of the physician examination and self examination of the skin. CA Cancer J Clin 1993;35:130-51.
35. MacKie RM, Hole D. Audit of public education campaign to encourage earlier detection of malignant melanoma. BMJ 1992;304:1012-15.
36. Melia J, Moss S, Graham-Brown R. et al. The relation between mortality from maliganant melanoma and early detection in the Cancer research Campaign Mole Watcher Study. Br J Cancer 2001;85:803-7.
37. Farmer ER, Gonin R, Hanna MP. Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum Pathol 1996;27:528-31.
38. Berwick M, Begg CB, Fine JA. Screening for cutaneous melanoma by skin self-examination. J Natl Cancer Inst 1996;88:17-23.
39. Ferrini RL, Perlman M, Hill L. Screening for Skin Cancer. American College of Preventive Medicine: Practice Policy Statement, 1998. Am J Prev Med 1998;14:80-2.
40. Asri GD, Clarke WH Jr, Guerry DV et al. (1990) Screening and surveillance of patients at high risk for malignant melanoma result in the detection of earlier disease. J Am Acad Dermatol 1990;22:1042-8.
41. Melia J, Harland C, Moss S, Eiser JS, Pendry L. Feasibility of targeted early detection for melanoma: a population-based screening study. Br J Cancer 2000;82: 1605-9.
42. Altman JF, Oliveria SA, Christos PJ, Halpern AC. A survey of skin cancer screening in the primary care setting: a comparison with other cancer screenings. Arch Fam Med 2000;10:1022-7.
43. Lorentzen HF, Weismann K. Dermatoscopic diagnosis of cutaneous melanoma. Secondary prophylaxis. Ugeskr Laeger 1993;162:3312-16.
44. Bafounta ML, Beauchet A, Aegerter P, Saiag P. Is dermoscopy useful for the diagnosis of melanoma? Results of a meta-analysis using techniques adapted to the evaluation of diagnostic tests. Arch Dermatol 2001;137:1343-50.
45. MacKie RM, Fleming C, McMahon AD, Jarrett P. The use of dermatoscope to identify early melanoma using the three colour test. Br J Dermatol 2002;146:481-4.
46. Girgis A, Sanson-Fisher RW. Skin cancer prevention, early detection, and management: current beliefs and practices of Australian family physicians. Cancer Detect Prev 1996;20:16-24.
Was this article helpful?
Complete Guide to Preventing Skin Cancer. We all know enough to fear the name, just as we do the words tumor and malignant. But apart from that, most of us know very little at all about cancer, especially skin cancer in itself. If I were to ask you to tell me about skin cancer right now, what would you say? Apart from the fact that its a cancer on the skin, that is.